Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015

BACKGROUND: Medical therapy for multiple sclerosis (MS) is expensive. Quantifying the burden of MS is fundamental for health-care planning and the allocation of resources for the management of MS. This study provides current national estimates of prevalence, incidence, mortality, and costs of MS in...

Descripción completa

Detalles Bibliográficos
Autores principales: Blozik, Eva, Rapold, Roland, Eichler, Klaus, Reich, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677381/
https://www.ncbi.nlm.nih.gov/pubmed/29138568
http://dx.doi.org/10.2147/NDT.S143180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677381/
https://www.ncbi.nlm.nih.gov/pubmed/29138568
http://dx.doi.org/10.2147/NDT.S143180

Ejemplares similares